Martin I. Freed

Insider Reports History

Location
Cambridge, MA
Signature
/s/ by David Tyronne Howton as attorney-in-fact for Martin I Freed
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin I. Freed:

Company Role Class Num Shares Value Price $ Report Date Ownership
Solid Biosciences Inc. Director Director Stock Option (Right to Buy) 77,500 12 Jun 2025 Direct
Dicerna Pharmaceuticals Inc Director Common Stock 0 $38.25 28 Dec 2021 Direct
Dicerna Pharmaceuticals Inc Director Director Stock Option (Right to Buy) 0 28 Dec 2021 Direct
Dicerna Pharmaceuticals Inc Director Restricted Stock Units 0 28 Dec 2021 Direct

Insider Reports Filed by Martin I. Freed

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLDB Solid Biosciences Inc. 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:27
SLDB Solid Biosciences Inc. 11 Jun 2024 1 $0 4 Director 13 Jun 2024, 16:10
SLDB Solid Biosciences Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 21:14
SLDB Solid Biosciences Inc. 13 Dec 2022 1 $0 4 Director 15 Dec 2022, 17:14
SLDB Solid Biosciences Inc. 07 Jun 2022 1 $0 4 Director 09 Jun 2022, 16:51
/report/000139952921000199-freed-martin-i-2021-12-28 Dicerna Pharmaceuticals Inc 28 Dec 2021 8 -$127,487 4 Director 29 Dec 2021, 15:20
SLDB Solid Biosciences Inc. 16 Jun 2021 1 $0 4 Director 21 Jun 2021, 16:00
/report/000139952921000108-freed-martin-i-2021-06-03 Dicerna Pharmaceuticals Inc 03 Jun 2021 4 $0 4 Director 07 Jun 2021, 21:34